RSS

metastatic melanoma

The European initiation of a Phase II clinical trial studying the effectiveness of tumour infiltrating lymphocytes (TIL) therapy in the treatment of patients with metastatic melanoma has been announced by Sarah Cannon Research Institute — UK. more

News